OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of guanidine-containing backbone linkages on stereopure antisense oligonucleotides in the CNS
Kandasamy Pachamuthu, Yuanjing Liu, Vincent Aduda, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 10, pp. 5401-5423
Open Access | Times Cited: 52
Kandasamy Pachamuthu, Yuanjing Liu, Vincent Aduda, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 10, pp. 5401-5423
Open Access | Times Cited: 52
Showing 1-25 of 52 citing articles:
Amplifying gene expression with RNA-targeted therapeutics
Olga Khorkova, Jack Stahl, Aswathy Joji, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 539-561
Open Access | Times Cited: 70
Olga Khorkova, Jack Stahl, Aswathy Joji, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 539-561
Open Access | Times Cited: 70
Modern approaches to therapeutic oligonucleotide manufacturing
Richard Obexer, Molhm Nassir, Eddie Moody, et al.
Science (2024) Vol. 384, Iss. 6692
Closed Access | Times Cited: 26
Richard Obexer, Molhm Nassir, Eddie Moody, et al.
Science (2024) Vol. 384, Iss. 6692
Closed Access | Times Cited: 26
A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS/FTD
Tristan X. McCallister, Colin K.W. Lim, Madhurima Singh, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Tristan X. McCallister, Colin K.W. Lim, Madhurima Singh, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Recent Trends in Antisense Therapies for Duchenne Muscular Dystrophy
Harry Wilton-Clark, Toshifumi Yokota
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 778-778
Open Access | Times Cited: 33
Harry Wilton-Clark, Toshifumi Yokota
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 778-778
Open Access | Times Cited: 33
Development of nucleic acid medicines based on chemical technology
Yusuke Kawamoto, You Wu, Yuki Takahashi, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114872-114872
Closed Access | Times Cited: 23
Yusuke Kawamoto, You Wu, Yuki Takahashi, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114872-114872
Closed Access | Times Cited: 23
Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington’s disease
Kaili Ou, Qingqing Jia, Dandan Li, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Kaili Ou, Qingqing Jia, Dandan Li, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Preclinical evaluation of WVE-004, an investigational stereopure oligonucleotide for the treatment of C9orf72-associated ALS or FTD
Yuanjing Liu, Amy Andreucci, Naoki Iwamoto, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 558-570
Open Access | Times Cited: 37
Yuanjing Liu, Amy Andreucci, Naoki Iwamoto, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 558-570
Open Access | Times Cited: 37
From green innovations in oligopeptide to oligonucleotide sustainable synthesis: differences and synergies in TIDES chemistry
Lucia Ferrazzano, Dario Corbisiero, Alessandra Tolomelli, et al.
Green Chemistry (2023) Vol. 25, Iss. 4, pp. 1217-1236
Open Access | Times Cited: 22
Lucia Ferrazzano, Dario Corbisiero, Alessandra Tolomelli, et al.
Green Chemistry (2023) Vol. 25, Iss. 4, pp. 1217-1236
Open Access | Times Cited: 22
Impact of stereopure chimeric backbone chemistries on the potency and durability of gene silencing by RNA interference
Wei Liu, Naoki Iwamoto, Subramanian Marappan, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 9, pp. 4126-4147
Open Access | Times Cited: 22
Wei Liu, Naoki Iwamoto, Subramanian Marappan, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 9, pp. 4126-4147
Open Access | Times Cited: 22
Future directions for medicinal chemistry in the field of oligonucleotide therapeutics
Jonathan Hall
RNA (2023) Vol. 29, Iss. 4, pp. 423-433
Open Access | Times Cited: 18
Jonathan Hall
RNA (2023) Vol. 29, Iss. 4, pp. 423-433
Open Access | Times Cited: 18
Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges
Cristina Hofman, David R. Corey
Cell chemical biology (2023) Vol. 31, Iss. 1, pp. 125-138
Open Access | Times Cited: 18
Cristina Hofman, David R. Corey
Cell chemical biology (2023) Vol. 31, Iss. 1, pp. 125-138
Open Access | Times Cited: 18
Long non-coding RNA-targeting therapeutics: discovery and development update
Olga Khorkova, Jack Stahl, Aswathy Joji, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 9, pp. 1011-1029
Closed Access | Times Cited: 16
Olga Khorkova, Jack Stahl, Aswathy Joji, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 9, pp. 1011-1029
Closed Access | Times Cited: 16
Phosphoramidate Azole Oligonucleotides for Single Nucleotide Polymorphism Detection by PCR
Alexey S. Chubarov, Elizaveta E. Baranovskaya, Igor P. Oscorbin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 617-617
Open Access | Times Cited: 5
Alexey S. Chubarov, Elizaveta E. Baranovskaya, Igor P. Oscorbin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 617-617
Open Access | Times Cited: 5
Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking
Priyanka Mangla, Quentin Vicentini, Annabelle Biscans
Cells (2023) Vol. 12, Iss. 18, pp. 2253-2253
Open Access | Times Cited: 13
Priyanka Mangla, Quentin Vicentini, Annabelle Biscans
Cells (2023) Vol. 12, Iss. 18, pp. 2253-2253
Open Access | Times Cited: 13
Preclinical evaluation of stereopure antisense oligonucleotides for allele-selective lowering of mutant HTT
Naoki Iwamoto, Yuanjing Liu, Maria Frank-Kamenetsky, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102246-102246
Open Access | Times Cited: 4
Naoki Iwamoto, Yuanjing Liu, Maria Frank-Kamenetsky, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102246-102246
Open Access | Times Cited: 4
Rational design of base, sugar and backbone modifications improves ADAR-mediated RNA editing
Genliang Lu, Chikdu Shivalila, Prashant Monian, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 17, pp. 10068-10084
Open Access | Times Cited: 4
Genliang Lu, Chikdu Shivalila, Prashant Monian, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 17, pp. 10068-10084
Open Access | Times Cited: 4
The MOE Modification of RNA: Origins and Widescale Impact on the Oligonucleotide Therapeutics Field
Alyssa C. Hill, Jonathan Hall
Helvetica Chimica Acta (2023) Vol. 106, Iss. 3
Open Access | Times Cited: 10
Alyssa C. Hill, Jonathan Hall
Helvetica Chimica Acta (2023) Vol. 106, Iss. 3
Open Access | Times Cited: 10
Progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy
Katarzyna Chwalenia, Matthew J. A. Wood, Thomas C. Roberts
Journal of Muscle Research and Cell Motility (2025)
Open Access
Katarzyna Chwalenia, Matthew J. A. Wood, Thomas C. Roberts
Journal of Muscle Research and Cell Motility (2025)
Open Access
Synthesis and physicochemical properties of new phosphoramide oligodeoxyribonucleotides. I. N-caffeine derivatives
Alina I Novgorodtseva, Aleksey Yu. Vorob’ev, Alexander A. Lomzov, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108313-108313
Closed Access
Alina I Novgorodtseva, Aleksey Yu. Vorob’ev, Alexander A. Lomzov, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108313-108313
Closed Access
Antisense Oligonucleotides: A Promising Advancement in Neurodegenerative Disease Treatment
Katarzyna Dudzisz, Ilona Wandzik
European Journal of Pharmacology (2025), pp. 177644-177644
Closed Access
Katarzyna Dudzisz, Ilona Wandzik
European Journal of Pharmacology (2025), pp. 177644-177644
Closed Access
Manufacturing of oligonucleotides
Eduardo Paredes, Vincent Aduda, Kathryn L. Ackley, et al.
Elsevier eBooks (2025)
Closed Access
Eduardo Paredes, Vincent Aduda, Kathryn L. Ackley, et al.
Elsevier eBooks (2025)
Closed Access
Effect of the Phosphoryl Guanidine Modification in Chimeric DNA–RNA crRNAs on the Activity of the CRISPR-Cas9 System In Vitro
Daria V. Prokhorova, Maxim S. Kupryushkin, Sergey A. Zhukov, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 6, pp. 1311-1319
Closed Access | Times Cited: 3
Daria V. Prokhorova, Maxim S. Kupryushkin, Sergey A. Zhukov, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 6, pp. 1311-1319
Closed Access | Times Cited: 3
Recent Trends in Antisense Therapies for Duchenne muscular dystrophy
Harry Wilton-Clark, Toshifumi Yokota
(2023)
Open Access | Times Cited: 8
Harry Wilton-Clark, Toshifumi Yokota
(2023)
Open Access | Times Cited: 8
Structure-activity relationship study of mesyl and busyl phosphoramidate antisense oligonucleotides for unaided and PSMA-mediated uptake into prostate cancer cells
Olga V. Sergeeva, E.A. Akhmetova, Svetlana Dukova, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
Olga V. Sergeeva, E.A. Akhmetova, Svetlana Dukova, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
Discovery and characterization of stereodefined PMO-gapmers targeting tau
Kunihiko Kanatsu, Yoshinori Takahashi, Tetsuya Sakaguchi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Kunihiko Kanatsu, Yoshinori Takahashi, Tetsuya Sakaguchi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
